A study has found that in patients with ischemic heart disease receiving ventricular tachycardia ablation there is higher risk of mortality.

The initial clinical assessments elicited stark awareness of a syndromic condition of varied causes (originally rheumatic heart disease, hypertension, and coronary disease) characterized by abysmal ...

A recent study has raised concerns about a possible link between a common type of blood pressure medication and an increased ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic ...

The global Heart Failure Drugs Market is valued at $8.6 billion in 2024 and is projected to reach a value of $21.4 billion by 2035. This growth represents a Compound Annual Growth Rate (CAGR) of 12.1% ...

"We found that antidepressants were associated with worse cognitive decline, but not all antidepressants were equal. Our ...

angiotensin II-receptor antagonists and dihydropyridine calcium channel blockers, with five having ARR results below 70 pmol/mU but considered suspicious for PA in the context of interfering ...

This study compared blood pressure (BP) control (tight vs usual) and the drug classes for starting treatment (calcium channel blockers, angiotensin receptor blockers, or angiotensin-converting enzyme ...

Angiotensin-converting enzyme (ACE) inhibitors are oral medications that lower blood pressure. They are used to treat a variety of heart-related conditions including high blood pressure, coronary ...

The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Currently, there is evidence supporting the use of either an angiotensin receptor blocker or an angiotensin-converting enzyme inhibitor in the primary-prevention context. However, in the secondary ...